← SynDRA
TYRPHOSTIN AG 879
SynDRA canonical compound SYN0019614 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ERBB2 | KDR | NTRK1 |
|---|
| Mechanism of action | tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
Cross-references
Synonyms
- RefChem:900834
- tyrphostin-AG-879
- AG 879
- AG879
- MFCD00236450
- C18H24N2OS
- alpha-Cyano-(3,5-di-t-butyl-4-hydroxy)thiocinnamide
- TyrphostinAG879
- tyrphostin AG879
- BiomolKI_000028
- Lopac-T-2067
- BiomolKI2_000036
- Lopac0_001175
- BMK1-D4
- BSPBio_001398
- SCHEMBL607701
- GTPL4863
- orb1300532
- BCBcMAP01_000075
- CHEBI:93041
- XRZYELWZLNAXGE-KPKJPENVSA-N
- GLXC-07087
- HMS1361F20
- HMS1791F20
- HMS1989F20
- HMS3263L11
- HMS3402F20
- CS-D0050
- EX-A1893
- Tyrphostin AG 879 (AG 879)
- Tox21_501175
- AG879?
- BDBM50468261
- EI-258
- s2816
- AKOS024256594
- CCG-100632
- LP01175
- SDCCGSBI-0051142.P002
Look up TYRPHOSTIN AG 879 in the interactive SynDRA portal →